The hydroxyl radical scavenger MCI-186 protects the liver from experimental cold ischaemia-reperfusion injury

The hydroxyl radical scavenger MCI-186 protects the liver from experimental cold ischaemia-reperfusion injury
复制标题

DOI:
10.1002/bjs.4401
复制
发表时间:
2004-02-01
影响因子:
9.6
通讯作者:
Maehara, Y
Maehara, Y
中科院分区:
医学1区
文献类型:
--
作者:
Ninomiya, M;Shimada, M;Maehara, Y

文献摘要

被引文献

相似文献

背景:氧化应激以双相模式参与肝脏缺血再灌注(IR)损伤。除了直接的细胞毒性作用外,氧化应激还启动促进第二阶段肝损伤的信号转导过程。本研究探讨了羟基自由基清除剂MCI-186对肝脏冷IR损伤的双相过程的影响。方法:大鼠肝脏冷保存16 h后,在离体肝脏灌注系统上用含氧Krebs-Henseleit碳酸氢盐缓冲液再灌注120 min。连续获得灌注液样本,并记录门静脉流速。为了确定MCI-186是否影响控制第二阶段损伤的细胞因子水平,在灌注液中测量白细胞介素(IL)10和肿瘤坏死因子(TNF)α的水平。向灌注液中添加1 mg/l MCI-186可显着改善门静脉流量(P <0.050)、肝酶释放量(P = 0.038)、总胆汁生成量(P = 0.029)和丙二醛(P = 0.038)。此外,用MCI-186处理导致IL-10释放的显著增加(P = 0.032)。结论:MCI-186,一种可供临床使用的药物,似乎对肝脏冷IR损伤有直接和间接的保护作用。
Background: Oxidative stress contributes to hepatic ischaemia-reperfusion (IR) injury in a biphasic pattern. In addition to direct cytotoxic effects, oxidative stress also initiates the signal transduction processes that promote second-phase liver injury. The present study investigated the effects of the hydroxyl radical scavenger MCI-186 on the biphasic process of hepatic cold IR injury.Methods: After cold preservation for 16 h, rat livers were reperfused on an isolated liver perfusion system for 120 min with oxygenated Krebs-Henseleit bicarbonate buffer. Perfusate samples were obtained serially, and portal flow rates were also recorded. To determine whether MCI-186 affected cytokine levels that control the second-phase injury, levels of interleukin (IL) 10 and tumour necrosis factor (TNF) alpha were measured in the perfusate.Results: Addition of MCI-186 1 mg/l into the perfusate significantly improved portal flow (P < 0.050), hepatic enzyme release into the perfusate (P = 0.038), total bile production (P = 0.029) and malondialdehyde concentration (P = 0.038). Furthermore, treatment with MCI-186 led to a substantial increase in IL-10 release (P = 0.032). TNF-alpha levels were not affected.Conclusions: MCI-186, an agent ready for clinical use, appears to have direct and indirect protective effects against hepatic cold IR injury.